Legislation roundup: Pharma patents, AI medical software and patent pledges

July 23, 2021 | BY

Susan Mok

An early resolution mechanism is in place for pharmaceutical patent disputes. Artificial intelligence medical software products are defined. Rules for registration of patent pledges are revised.

Healthcare

National Medical Products Administration and China National Intellectual Property Administration, Implementing Measures for the Mechanism for the Early Resolution of Pharmaceutical Patent Disputes (Trial Implementation)

国家药品监督管理局、国家知识产权局药品专利纠纷早期解决机制实施办法 (试行)

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]